期刊文献+

辛伐他汀对急性冠脉综合征患者肿瘤坏死因子及一氧化氮含量的影响

Effect of Simvastatin on Concentration of TNF-α and NO in Patients wit h Acute Coronary Syndromes
下载PDF
导出
摘要 目的: 探讨辛伐他汀对急性冠脉综合征(ACS)患者血清肿瘤坏死因子- α(TNF -α)及一氧化氮(NO)含量变化的影响。方法: 采用双盲法将55例急性冠状动脉综合征患者随机分为辛伐他汀组(n=27例)和常规治疗组(n=28例),分别于治疗前及治疗后3周行血清TNF- α及NO检测。结果:①辛伐他汀组治疗后与治疗前比较,血清TNF α明显降低,NO显著升高(P<0 .01);②常规组治疗前后,血清TNF- α、NO变化不明显(P>0 .05)。结论: 辛伐他汀可降低急性冠脉综合征患者血TNF- α水平,升高NO水平,具有稳定粥样斑块和保护血管内皮的作用。 Objective:To investigate the effect of simvastatin on changes in serum concentrations of NO and tumor necrosis factor-α (TNF-α ) in patients with acute coronary syndromes (ACS). Methods:55 patients with ACS were randomly divided into simvastatin group (n=27) and routi ne therapy group (n=28).Serum TNF-α and NO levels were measured before and thr ee weeks after the two treatment options respectively.Results: ①The level of TNF-α was decreased significantly and NO content got increased markedly after simvastatin therapy(P<0.01).②The concentrations of TNF- α and NO changed only slightly after the routine therapy(P>0.05).C onclusions:Simvastatin could reduce the levels of TNF-α and increase NO concentration in patients with ACS,stabilizing atherosclerotic plaque and pro tecting the endothelial function.
出处 《临床误诊误治》 2005年第3期153-155,共3页 Clinical Misdiagnosis & Mistherapy
关键词 辛伐他汀 冠脉综合征 肿瘤坏死因子 一氧化氮 治疗 Simvastatin Acute coronary syndromes Tumor necrosis factor-α Nitric oxide Therapy
  • 相关文献

参考文献11

  • 1Conci CR. Updated pathophysiologic concepts in unstable coronary artery disease[J]. Am Heart J,2001, 141 (2 Suppl) :S12-14.
  • 2Downs JR,Clearfield M,Weis S,et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study[J]. JAMA, 1998,279:1615-1622.
  • 3Bellosta S,Via D,Canavesi M,et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J]. Arterioscler Thromb Vasc Biol, 1998,18:1671-1978.
  • 4徐成斌.论急性冠状动脉综合征他汀类药物早期应用的益处[J].中华心血管病杂志,2001,29(3):129-131. 被引量:104
  • 5Schwartz GG,Olsson AG,Ezekowitz MD,et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study: a randomized controlled trial[J]. JAMA ,2001,285:1711-1718.
  • 6Barath P, Fishbein MC, Cao J, et al. Tumor necrosis factor gene expression in human vascular intimal smooth, muscle cells detected by in situ hybridization [J]. Am J Pathol,1990,137:503-509.
  • 7Tipping PG, Hancock WW. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques[J]. Am J Pathol, 1993,142:1721-1728.
  • 8Moncada S,Palmer RM,Higgs EA. Nitric oxide: physiology,pathophysiology and pharmacology [J]. Pharmacol Rev,1991,43:109-142.
  • 9Kaesemeyer WH, Caldwell RB, Huang J,et al. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions [J]. J Am Coll Cardiol,1999,33:234-241.
  • 10Bradford Sanders D, Hunter K,Wu Y,et al. Modulation of the inflammatory response in the cardiomyocyte and macrophage [J]. J Extra Corpor Technol,2001,33 :167-174.

共引文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部